Nahum Sanchez-Mendez

Mexico City, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 332 publications

THE SIMPLEST HEPATOPROTECTIVE INTERVENTION? COFFEE IN THE ERA OF PRECISION HEPATOLOGY.

THE SIMPLEST HEPATOPROTECTIVE INTERVENTION? COFFEE IN THE ERA OF PRECISION HEPATOLOGY.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 08, 2026

Clinical Relevance of Bile Acid and Bile Acid-Related Therapy in Liver Cirrhosis: A Review.

Clinical Relevance of Bile Acid and Bile Acid-Related Therapy in Liver Cirrhosis: A Review.

Journal: Advances in therapy

Published: April 28, 2026

Understanding Liver and Digestive Diseases: A Paved Road to Improve Diagnosis, Management, and Treatment.

Understanding Liver and Digestive Diseases: A Paved Road to Improve Diagnosis, Management, and Treatment.

Journal: Exploration of digestive diseases

Published: April 09, 2026

From NAFLD to MASLD and MetALD: Conceptual Shifts in Metabolic Liver Disease and Their Implications for Mexico.

From NAFLD to MASLD and MetALD: Conceptual Shifts in Metabolic Liver Disease and Their Implications for Mexico.

Journal: Medicina (Kaunas, Lithuania)

Published: March 10, 2026

Associations of Helicobacter pylori infection with NAFLD, MAFLD, MASLD, and Chinese MAFLD.

Associations of Helicobacter pylori infection with NAFLD, MAFLD, MASLD, and Chinese MAFLD.

Journal: Therapeutic advances in gastroenterology

Published: February 13, 2026

Ishak stage 6 fibrosis is more likely to regress than stage 5 in CHB patients undergoing entecavir therapy.

Ishak stage 6 fibrosis is more likely to regress than stage 5 in CHB patients undergoing entecavir therapy.

Journal: Frontiers in medicine

Published: December 11, 2025

Delphi survey to explore core curriculum for training the next-generation of hepatologists☆.

Delphi survey to explore core curriculum for training the next-generation of hepatologists☆.

Journal: JHEP reports : innovation in hepatology

Published: December 10, 2025

Efficacy and safety of statins for nonalcoholic/metabolic dysfunction-associated fatty liver diseases: a systematic review and meta-analysis.

Efficacy and safety of statins for nonalcoholic/metabolic dysfunction-associated fatty liver diseases: a systematic review and meta-analysis.

Journal: Expert review of clinical pharmacology

Published: December 04, 2025

Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study.

Impact of Fatigue on Patient-Reported Outcomes and Work Productivity in Chronic Hepatitis B and C: Insights From a Multinational Registry Study.

Journal: Journal of viral hepatitis

Published: November 04, 2025

Pirfenidone as a Pleiotropic Antifibrotic Agent in Metabolic Steatohepatitis: From Mechanisms to Clinical Evidence.

Pirfenidone as a Pleiotropic Antifibrotic Agent in Metabolic Steatohepatitis: From Mechanisms to Clinical Evidence.

Journal: Archives of medical research

Published: October 31, 2025

Hot Topics in Gastroenterology and Hepatology.

Hot Topics in Gastroenterology and Hepatology.

Journal: Archives of medical research

Published: October 29, 2025

Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement.

Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement.

Journal: Gut

Published: October 23, 2025

Showing 1-12 of 332

Last Updated: 09/26/2026